Search for added value

To find the right contract manufacturer to make high-quality products, service providers need to be evaluated according to an objective catalogue of criteria, and against subjective factors. Product quality and low price were always the decisive factors in selecting a service provider to deal with the contract manufacture of pharmaceuticals.

However, since quality and a competitive price became basic market prerequisites quite some time ago, new standards have to be applied when assessing the range of services offered by a provider to select the right contract manufacturer for a company’s individual needs.

If increasing demand, a lack of resources or a company’s strategic orientation requires collaboration with a contract manufacturer, the relevant decision-makers will look for a partner who at least meets, if not exceeds, their own standards.

A contract manufacturer may offer a high-quality product at a cost-effective price, but that will not be enough to make it stand out from its rivals. Customers have now come to expect high-quality products at a competitive price as standard and there are many contract manufacturers capable of meeting this expectation. Therefore, the best way to differentiate between providers is to look at the quality of the service they offer and the customer benefits they create.

Determining value
More and more, a contract manufacturer’s failure or success in the market is determined by the added value it can generate for a customer through its services.

Responsiveness refers to the contract manufacturer’s ability to meet the customer’s communication needs at any time and to see things from the customer’s point of view throughout. Reliability means providing cover for the customer against market challenges against statutory general conditions defined by product quality and regulatory compliance. Flexibility, in terms of both quantities and deadlines, means the contract manufacturer is adaptable to changing customer requirements, giving the client a lasting competitive advantage in markets that are fast moving and highly competitive.

Responsiveness, reliability and flexibility are the criteria against which a contract manufacturer’s ability to provide added value must be measured. A consistent focus on added value must be based on professional expertise and international industry experience.

Extensive experience
Many years of specialisation in parenteral forms of administration and extensive international experience are the hallmarks of hameln pharmaceuticals GmbH.

In the 1970s, this independent, owner-managed family business began specialising exclusively in the contract manufacture of sterile pharmaceuticals. Since then, the company has expanded its range and now offers complex, high-quality products that are supplied in glass containers, including anaesthetics, flammable liquids, suspensions, oily solutions and cold-chain drugs. Aseptic production is at the heart of the company’s manufacturing activities.

As a company that makes more than 60% of its turnover from export sales, hameln pharmaceuticals works in accordance with EU and FDA cGMP guidelines and is certified accordingly.

Thanks to specially drawn up transfer documents based on the HACCP concept, it takes less than six months, on average, to perform site transfer and fully set up a new product.

To be in a position to provide maximum added value, hameln pharmaceuticals bears the three criteria of responsiveness, reliability and flexibility in mind in all it does. As a specialist in the contract manufacture of pharmaceuticals, hameln pharmaceuticals speaks the same language as its customers, recognises their problems and proposes individual solutions tailored to individual requirements.

In order to continue providing this service in the future, hameln pharmaceuticals
is investing in its German headquarters by erecting a new production building, among other projects. From 2008, customers will be able to call on twice as much state-of-the-art production capacity for their products. Of course, the company will also continue to deliver a comprehensive range of services that can be tailored to individual customer requirements.

Company profile
hameln pharmaceuticals manufactures parenteral solutions and suspensions, aseptic and terminally sterilised, in glass containers.

For further information, visit www.hm-ph-group.com.

< Back to Contract services index

< Back to Market Resources index